Edesa Biotech P/L
Qual é o P/L de Edesa Biotech?
O P/L de Edesa Biotech, Inc. é N/A
Qual é a definição de P/L?
A razão entre preço e lucro é a razão entre o preço das ações de uma empresa e o lucro por ação da empresa, calculado ao longo de doze meses.
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
P/L de empresas na Setor Health Care em NASDAQ em comparação com Edesa Biotech
O que Edesa Biotech faz?
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chronic allergic contact dermatitis. It has a license agreement with NovImmune SA to develop monoclonal antibodies targeting TLR4 and CXCL10. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada.
Empresas com p/l semelhantes a Edesa Biotech
- Cannabix Technologies tem P/L de N/A
- Antalis Ventures tem P/L de N/A
- Fosterville South Exploration tem P/L de N/A
- hmvod tem P/L de N/A
- Commander Resources tem P/L de N/A
- Rugby Mining tem P/L de N/A
- Edesa Biotech tem P/L de N/A
- Unitech tem P/L de N/A
- Directa Plus Plc tem P/L de N/A
- GURU Organic tem P/L de N/A
- Amasse Capital tem P/L de N/A
- Chen Xing Development tem P/L de N/A
- Icade SA tem P/L de N/A